Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma
- Citation:
- JAMA Oncol vol 5 (11) 1582-1588
- Year:
- 2019
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Pharmas:
- Bayer
- Grants:
- U10CA180821, U10CA180882, U10CA077202, U10CA180820, U10CA180830, U10CA189859, U10CA180888, UG1CA189821
- Corr. Author:
- Authors:
- Ghassan K. Abou-Alfa Qian Shi Jennifer J. Knox Andreas Kaubisch Donna Niedzwiecki James Posey Benjamin R. Tan Jr. Petr Kavan Rakesh Goel Philip E. Lammers Tanios S. Bekaii-Saab Vincent C. Tam Lakshmi Rajdev Robin K. Kelley Imane El Dika Tyler Zemla Ryan I. Potaracke Jennifer Balletti Anthony B. El-Khoueiry James J. Harding Jennifer M. Suga Lawrence H. Schwartz Richard M. Goldberg Monica M. Bertagnolli Jeffrey Meyerhardt Eileen M. O'Reilly Alan P. Venook
- Networks:
- BAPTIST, CA011, CA136, KAISER, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NY016, LAPS-OH007, MN022, MONTEFIORE, NY021, PA121
- Study
- CALGB-80802
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Research, Research, Original Investigation, Online First